23.03.2010 • News

Glaxo Nabs L'Oreal Exec To Head Consumer Health

GlaxoSmithKline has poached a top executive from French cosmetics group L'Oreal as president-designate of its consumer healthcare unit, underscoring the drugmaker's diversification drive. The British-based group said on Monday that Emma Walmsley, leader of L'Oreal's consumer products business in China, would run consumer healthcare in Europe from May 1 and take over from John Clarke as worldwide consumer head within two years.

Glaxo has come under pressure in the past to spin off consumer health, but under new chief executive Andrew Witty, the division has become a key pillar of the drugmaker's drive to reduce reliance on traditional prescription pharmaceuticals. Glaxo's consumer business includes over-the-counter medicines, toothpaste and nutritional drinks such as Lucozade.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.